Cargando…

Editorial: Immunometabolism and therapeutic targeting of aggressive cancers

Detalles Bibliográficos
Autores principales:	Ždralević, Maša, Pouysségur, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291691/ https://www.ncbi.nlm.nih.gov/pubmed/37377913 http://dx.doi.org/10.3389/fonc.2023.1226078

Ejemplares similares

Metabolic Plasiticy in Cancers—Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs
por: Ždralević, Maša, et al.
Publicado: (2017)

Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer
por: Cassim, Shamir, et al.
Publicado: (2020)

Targeting Immunometabolism in Glioblastoma
por: Mohan, Aditya A., et al.
Publicado: (2021)

Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications
por: Yang, Miner, et al.
Publicado: (2021)

Targeting T Cell Immunometabolism for Cancer Immunotherapy; Understanding the Impact of the Tumor Microenvironment
por: Mockler, Mary B., et al.
Publicado: (2014)

Metabolic Rewiring toward Oxidative Phosphorylation Disrupts Intrinsic Resistance to Ferroptosis of the Colon Adenocarcinoma Cells
por: Gotorbe, Célia, et al.
Publicado: (2022)

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas
por: Witte, Hanno Maximilian, et al.
Publicado: (2023)

Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer
por: Fox, Eric, et al.
Publicado: (2018)

Targeting Cancer Metabolism Breaks Radioresistance by Impairing the Stress Response
por: Schwab, Melissa, et al.
Publicado: (2021)

The role of mitochondria in yeast programmed cell death
por: Guaragnella, Nicoletta, et al.
Publicado: (2012)

Editorial: Skeletal Muscle Immunometabolism
por: Trollet, Capucine, et al.
Publicado: (2021)

Cysteine Depletion, a Key Action to Challenge Cancer Cells to Ferroptotic Cell Death
por: Daher, Boutaina, et al.
Publicado: (2020)

Immunometabolism in the tumor microenvironment and its related research progress
por: Zhang, Ziheng, et al.
Publicado: (2022)

Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers
por: Lu, Ziwen, et al.
Publicado: (2022)

Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
por: Marchiq, Ibtissam, et al.
Publicado: (2015)

Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma
por: Rad Pour, Soudabeh, et al.
Publicado: (2020)

Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism
por: Alshahrani, Shadia Hamoud, et al.
Publicado: (2022)

The Central Role of Amino Acids in Cancer Redox Homeostasis: Vulnerability Points of the Cancer Redox Code
por: Vučetić, Milica, et al.
Publicado: (2017)

Editorial: Metabolism As a Therapeutic Target
por: Columbano, Amedeo, et al.
Publicado: (2017)

Editorial: Immunometabolism in autoimmune and autoinflammatory disorders
por: Zheng, Fang, et al.
Publicado: (2023)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
por: Duan, Wanxing, et al.
Publicado: (2022)

Editorial: Immunometabolic response of natural products in inflammation and cancer
por: Tan, Wen, et al.
Publicado: (2023)

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer
por: Zhong, Weilong, et al.
Publicado: (2023)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets
por: Pessoa, João, et al.
Publicado: (2022)

Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance
por: Traba, Javier, et al.
Publicado: (2021)

Targeting Aggressive Cancer Stem Cells in Glioblastoma
por: Seymour, Tracy, et al.
Publicado: (2015)

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
por: Naik, Adviti, et al.
Publicado: (2022)

Editorial: Sex differences in immunometabolism, prophylaxis and therapy
por: Fink, Ashley, et al.
Publicado: (2023)

Editorial: Obesity and Diabetes: Implications for Brain-Immunometabolism
por: Gaspar, Joana M., et al.
Publicado: (2020)

Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022)

Editorial: Identification of therapeutic targets and novel biomarkers in prostate cancer volume II
por: Sharad, Shashwat, et al.
Publicado: (2023)

Editorial: Human and Oncoviral Non-Coding RNAs as Modulators of Cancer Aggressiveness and Disease Progression
por: Reis, Patricia P., et al.
Publicado: (2021)

Editorial: Immunometabolism of T cells in skin infection, autoimmunity and cancer biology
por: Peng, Lu, et al.
Publicado: (2023)

Editorial: Tumor Cell Metabolism and Autophagy as Therapeutic Targets
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2020)

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II
por: Zhong, Weilong, et al.
Publicado: (2023)

Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II
por: Pessoa, João, et al.
Publicado: (2023)

Editorial: Combining multiple non-invasive images and/or biochemical tests to predict prostate cancer aggressiveness
por: Mayer, Rulon, et al.
Publicado: (2023)

Nutraceuticals as Potential Therapeutic Modulators in Immunometabolism
por: Alba, Gonzalo, et al.
Publicado: (2023)

Editorial: Therapeutic Targeting of Cancer Stem-Like Cells (CSC) – The Current State of the Art
por: Corbet, Cyril, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pqm24eatf2pm5iba7lc1en9lpb